Gulf Inject

What Gulf Inject does

Gulf Inject is a UAE-based pharmaceutical manufacturer founded in 1994 that produces sterile injectable medicines and fluid management therapies for hospitals, healthcare facilities, and international pharmaceutical brand partners. The company operates from an 11,000 sqm state-of-the-art production facility in JAFZA, Dubai, with an additional 9,000 sqm expansion underway. Its portfolio spans more than 65-70 SKUs across six categories: general intravenous solutions, hypertonic solutions, local anaesthetics, antimicrobial IV solutions, irrigation solutions, and nebulizer solutions.

The company's core production technology is Blow-Fill-Seal (BFS) manufacturing, an aseptic processing method that forms, fills, and seals containers in a single continuous operation, reducing contamination risk for sterile injectables. Production is conducted under ISO 9001:2015, ISO 14001:2015, OHSAS 18001:2007, and ISO 13485:2016 certifications, and is stated to be compliant with UAE, WHO, GMP, and cGMP regulatory regimes. Gulf Inject also operates as a contract manufacturer for international pharmaceutical brands seeking GMP-certified aseptic capacity in the MENA region.

Gulf Inject generates revenue through B2B product sales of sterile pharmaceuticals, delivered via direct supply relationships with hospitals alongside distribution partnerships across the MENA region covering UAE, Iraq, KSA, Yemen, Libya, Sudan, Jordan, Bahrain, Oman, and Kuwait. The company is a wholly-owned subsidiary of GlobalOne Healthcare Holding (GHH) and was part of strategic acquisitions by UAE sovereign wealth funds Mubadala and ADQ during the 2021-2025 GCC healthcare investment cycle. Pricing is not publicly disclosed and operates as standard institutional B2B pharmaceutical supply.

Name

Gulf Inject

Legal name

Gulf Inject

Website

https://gulfinject.com

Company type

Private

Founded year

1994

Operating status

Operating

Short description

Gulf Inject is a UAE-based sterile injectable pharmaceutical manufacturer founded in 1994, producing 65+ injectable, IV, and fluid management products via Blow-Fill-Seal technology from its JAFZA Dubai facility for hospitals and international pharma brands across the MENA region.

Ownership category

akta.pro rank

Product category

Sterile Injectable Pharmaceutical Manufacturing

NAICS

Pharmaceutical Preparation Manufacturing (325412)

SIC

Pharmaceutical Preparations (2834)

akta.pro primary industry

Nebulizers & Aerosol Drug Delivery Systems (HLAHAIAJ)

Keywords

• Sterile injectables manufacturing
• Fluid management therapy
• Parenteral pharmaceutical solutions
• Intravenous infusion products
• Aseptic pharmaceutical production

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

1. Pharmaceutical Product Sales: Gulf Inject generates revenue through the manufacture and sale of sterile fluid management therapy products, including injectables, generic IV infusions, antibiotics, local anaesthetics, and hypertonic solutions to hospitals and healthcare facilities.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels1 record

Core offering

Gulf Inject manufactures and supplies sterile injectable pharmaceutical products and fluid management therapies, including general intravenous solutions, hypertonic solutions, local anaesthetics, antimicrobial IV antibiotics, irrigation solutions, and nebulizer solutions. The company produces a portfolio of 65+ products at its JAFZA Dubai facility using Blow-Fill-Seal aseptic processing technology, serving hospitals and healthcare facilities across the MENA region.

Product overview

Gulf Inject is a pharmaceutical manufacturer specializing in sterile fluid management therapy and parenteral healthcare solutions. The company operates a state-of-the-art production facility in JAFZA, Dubai, producing a portfolio of over 65-70 products across six core categories: General Intravenous Solutions (hydration, electrolytes, nutrition), Hypertonic Solutions (ophthalmology and specialized formulations), Local Anaesthetics (Lidocaine-based pain management), Antimicrobial IV Solutions (antibiotics including Metronidazole and Moxifloxacin), Irrigation Solutions (sterile cleansing), and Nebulizer Solutions (respiratory care). All products are manufactured using Blow-Fill-Seal technology under stringent quality controls compliant with WHO, GMP, and cGMP standards. The company serves leading hospitals and healthcare facilities across the MENA region as a subsidiary of GlobalOne Healthcare Holding (GHH).

Differentiator

Problem solved

Functional benefit

Products and services

• General Intravenous Solutions Essential general intravenous supplies for hospital and clinical use, including hydration and electrolyte solutions such as Sodium Chloride 0.9%, Compound Sodium Lactate, Ringer's Solution, and combination solutions with Glucose for electrolyte balance and nutrition. Intended for hospitals and healthcare facilities.
• Hypertonic Solutions Concentrated sterile solutions formulated to address specific medical conditions requiring higher osmotic pressure, including ophthalmology applications such as Aflibercept. Intended for hospitals and healthcare facilities.
• Local Anaesthetics Sterile pain management solutions for various medical procedures, including Lidocaine 1% and Lidocaine 2% formulations for local anesthesia. Intended for hospitals and healthcare facilities.
• Antimicrobial IV Solutions Advanced intravenous antibiotic formulations designed to safeguard against infections, including Metronidazole I.V. and Avafuse (Moxifloxacin). Intended for hospitals and healthcare facilities.
• Irrigation Solutions Sterile irrigation solutions for precise and gentle cleansing care, including Sodium Chloride 9g/100ml for optimal cleansing and soothing relief. Intended for hospitals and healthcare facilities.
• Nebulizer Solutions Specialized respiratory care solutions delivered via nebulization, including Sodium Chloride 0.9% for dilution of nebulisation solutions. Intended for hospitals and healthcare facilities.

Named customers2 records

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Partnerships

Two partnerships are on record, tiered core.

• GlobalOne Healthcare Holding (GHH)coreStrategic or Co-development PartnerGulf Inject is a subsidiary of GlobalOne Healthcare Holding (GHH), a prominent investment and business development organization operating within the healthcare industry in the UAE and internationally. GHH provides comprehensive healthcare solutions including pharmaceuticals, manufacturing, distribution, health-tech, and hospital management. Gulf Inject leverages GHH's expertise and network to achieve its mission of delivering medical solutions worldwide.
• Distribution Partners (MENA Region)coreChannel Partner/ Reseller/ DistributorGulf Inject has established distribution partnerships delivering high-quality sterile healthcare solutions to hospitals and healthcare facilities across the MENA region, ensuring best-in-class sterile fluid management therapy is available to those in need.

Scale indicators6 records

Recent moves5 records

Expansion highlights3 records

Direct peers

• Julphar (Gulf Pharmaceutical Industries): UAE-based pharmaceutical manufacturer producing generic medicines, injectables, and IV solutions for the MENA region. Directly comparable as a fellow GCC-headquartered sterile injectable and generic drug producer with overlapping product categories.
• Tabuk Pharmaceuticals: Saudi Arabia-based pharmaceutical manufacturer producing generics including sterile injectables for the GCC and wider MENA. Comparable as a regional generic injectable competitor targeting the same hospital customers.
• Neopharma: Abu Dhabi-headquartered pharmaceutical manufacturer focused on generic and specialty medicines including sterile injectables, with GMP-certified production serving the UAE and MENA. Comparable as a regional sterile injectable manufacturer with similar B2B hospital focus.
• Aurobindo Pharma: Indian-headquartered global generic injectables manufacturer with a large sterile injectables portfolio exported to MENA, Europe and emerging markets. Comparable as a competitor in generic sterile injectables including IV antibiotics and local anaesthetics.
• Hikma Pharmaceuticals: Jordan-headquartered multinational generic pharmaceutical manufacturer with a leading injectable franchise and MENA distribution. Highly comparable given its generic injectables portfolio, MENA roots, and direct competition in hospital tenders.
• SPIMACO (Saudi Pharmaceutical Industries & Medical Appliances): Saudi-listed pharmaceutical manufacturer producing generics, sterile injectables, and IV solutions across MENA. Comparable as a regional peer competing for the same hospital and government procurement contracts.

Emerging players

• Cipla: Indian-headquartered global pharmaceutical company with a growing sterile injectable franchise including local anaesthetics and antibiotics. Comparable as a generic injectable competitor expanding in MENA markets.

Broad incumbents

• Baxter International: Global leader in IV solutions, parenteral nutrition, and sterile fluids with deep MENA presence. Comparable as a broad incumbent supplying many of the same hospital customers with IV and irrigation solutions.
• Fresenius Kabi: Global provider of IV drugs, sterile fluids, infusion technology and clinical nutrition products. Comparable as a broad incumbent competing on the same IV solutions, antibiotics, and parenteral nutrition categories.
• B. Braun: German-headquartered global medical device and pharmaceutical solutions company with a large IV solutions and sterile fluids business. Comparable as a broad incumbent in sterile parenteral solutions sold to hospitals across MENA.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks7 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/gulfinject
• Facebookfacebook.com/GulfInjectLLC

Compliance5 records

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Gulf Inject